Cargando…
Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection
BACKGROUND: Here we describe the treatments and prognosis for metachronous metastases from gastroenteropancreatic neuroendocrine tumors (GEP-NETs) after initial R0 surgical resection at a large center in China. METHODS: The clinicopathological data and survival outcomes for 108 patients (median age,...
Autores principales: | Lv, Yang, Han, Xu, Xu, Xue-Feng, Ji, Yuan, Zhou, Yu-Hong, Sun, Hui-Chuan, Zhou, Jian, Fan, Jia, Lou, Wen-Hui, Huang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454726/ https://www.ncbi.nlm.nih.gov/pubmed/30961559 http://dx.doi.org/10.1186/s12885-019-5457-z |
Ejemplares similares
-
MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases
por: Zimmermann, Nadine, et al.
Publicado: (2018) -
Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
por: Gut, Paweł
Publicado: (2020) -
Gastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality
por: Fazio, Nicola, et al.
Publicado: (2017) -
Dynamic enhanced CT: is there a difference between liver metastases of gastroenteropancreatic neuroendocrine tumor and adenocarcinoma
por: Cui, Yong, et al.
Publicado: (2017) -
Primary Tumor Site Affects Survival in Patients with Gastroenteropancreatic and Neuroendocrine Liver Metastases
por: Tierney, John F., et al.
Publicado: (2019)